Vivek M Shastri, Ph.D.

Having obtained his Ph.D. training in cellular and molecular biology, Vivek Shastri joined Dr. Jatinder Lamba’s group in the PTR department at the UF College of Pharmacy. This allowed him to apply his skillset to translational research. One of his interests within the Lamba group is identification, characterization, and validation of pharmacogenomic markers to predict response to therapy in acute myeloid leukemia (AML) patients. He is also leading projects to develop and evaluate novel agents targeting CD33 isoforms to benefit AML patients not responding to currently available immunotherapy options. Another area of focus is understanding the role of senescence in promoting resistance and relapse in AML patients.